Stroke Diagnostics and Therapeutics - Global Market Outlook (2016-2022)

  • ID: 4428393
  • Report
  • Region: Global
  • 180 pages
  • Stratistics Market Research Consulting Pvt Ltd
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Coaxia Inc
  • Cordis Corporation
  • GE Healthcare
  • Genentech Inc.
  • Medtronic plc
  • MORE
According to MRC, the Global Stroke Diagnostics and Therapeutics market is accounted for $21.6 billion in 2015 and is expected to reach $35.6 billion by 2022 growing at a CAGR of 7.3% from 2015 to 2022. Factors such as technological advancement, growing aging population, and people suffering from diabetes, increasing health expenditure, hypertension and als-increasing tobacc-users will boost the market growth. However, factors such as unfavorable reimbursement scenari-and high cost of treatments are restraining the market growth.
North America commanded the largest market due to technologically advanced equipment for the diagnosis and improved healthcare infrastructure in this region. Asia Pacific is anticipated to witness fastest growth rate during the forecast period due to ongoing R&D activities for drug discovery and development and increasing government initiative in funding.
Some of the key players in global Stroke Diagnostics and Therapeutics market are Abbott Laboratories, Siemens AG, Stryker Corporation, GE Healthcare, Medtronic plc, Cordis Corporation, Genentech Inc., Boston Scientific Corporation, Coaxia Inc and Philips Healthcare.

Types Covered:
  • Diagnostics
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography Scan (CT scan)
  • Electrocardiography
  • Carotid Ultrasound
  • Others
  • Therapeutics
  • Tissue Plasminogen Activator
  • Antiplatelet
  • Antihypertensive
  • Anticoagulant
Applications Covered:
  • Haemorrhagic Stroke
  • Ischemic Stroke
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Coaxia Inc
  • Cordis Corporation
  • GE Healthcare
  • Genentech Inc.
  • Medtronic plc
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Stroke Diagnostics and Therapeutics Market, By Type
5.1 Diagnostics
5.1.1 Magnetic Resonance Imaging (MRI)
5.1.2 Computed Tomography Scan (CT scan)
5.1.3 Electrocardiography
5.1.4 Carotid Ultrasound
5.1.5 Others
5.2 Therapeutics
5.2.1 Tissue Plasminogen Activator
5.2.2 Antiplatelet
5.2.3 Antihypertensive
5.2.4 Anticoagulant

6 Global Stroke Diagnostics and Therapeutics Market, By Application
6.1 Introduction
6.2 Haemorrhagic Stroke
6.3 Ischemic Stroke

7 Global Stroke Diagnostics and Therapeutics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.7 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.7 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Abbott Laboratories
9.2 Siemens AG
9.3 Stryker Corporation
9.4 GE Healthcare
9.5 Medtronic plc
9.6 Cordis Corporation
9.7 Genentech Inc.
9.8 Boston Scientific Corporation
9.9 Coaxia Inc
9.10 Philips Healthcare

List of Tables

Table 1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Table 17 North America Stroke Diagnostics and Therapeutics Market Outlook, By Country (2013-2022) ($MN)
Table 18 North America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 19 North America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 20 North America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 21 North America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 22 North America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 23 North America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 24 North America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 25 North America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 26 North America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 27 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 28 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 29 North America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 30 North America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 31 North America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 32 North America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Table 33 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Country (2013-2022) ($MN)
Table 34 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 35 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 36 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 37 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 38 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 39 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 40 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 41 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 42 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 43 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 44 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 45 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 46 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 47 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 48 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Table 49 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Country (2013-2022) ($MN)
Table 50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Table 65 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Country (2013-2022) ($MN)
Table 66 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 67 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 68 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 69 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 70 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 71 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 72 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 73 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 74 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 75 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 76 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 77 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 78 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 79 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 80 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Siemens AG
  • Stryker Corporation
  • GE Healthcare
  • Medtronic plc
  • Cordis Corporation
  • Genentech Inc.
  • Boston Scientific Corporation
  • Coaxia Inc
  • Philips Healthcare
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll